Hypertension Trial, Recruiting (NCT06643741)

Hypertension Trial, Recruiting NCT06643741 Sponsor: Sequenom, Inc. Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT06643741 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The person enrolling must be female and at least 18 years old
The person must be willing to sign and date a consent form before joining
The person must be pregnant with a single baby (not twins or more) and between 11 and 14 weeks along in the pregnancy
The person must agree to allow the study sponsor to access results from any pregnancy-related screening or diagnostic tests
The person must agree to have two specific measurements taken during their routine first trimester ultrasound appointment — a blood flow measurement related to the uterus and a blood pressure reading
The person must agree to provide up to 25mL of blood (about 5 teaspoons) at each trimester visit
The person must agree to share relevant medical information and details about the pregnancy and its outcome

Who may not be able to join:

People who are unlikely to come back for testing during the second and third trimesters of pregnancy
People for whom information about how the pregnancy ends is unlikely to be available
People who have already provided a sample under this same study during the current pregnancy
People who are taking part in a blinded aspirin study, or who are taking aspirin at an unknown dose

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emily Rosenfeld, DO, Rutgers Robert Wood Johnson Medical School

Phone: (858) 202-9162

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06643741

Sponsor: Sequenom, Inc.

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: (858) 202-9162

More information: https://clinicaltrials.gov/study/NCT06643741

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The person enrolling must be female and at least 18 years old
The person must be willing to sign and date a consent form before joining
The person must be pregnant with a single baby (not twins or more) and between 11 and 14 weeks along in the pregnancy
The person must agree to allow the study sponsor to access results from any pregnancy-related screening or diagnostic tests
The person must agree to have two specific measurements taken during their routine first trimester ultrasound appointment — a blood flow measurement related to the uterus and a blood pressure reading
The person must agree to provide up to 25mL of blood (about 5 teaspoons) at each trimester visit
The person must agree to share relevant medical information and details about the pregnancy and its outcome

Who may not be able to join:

People who are unlikely to come back for testing during the second and third trimesters of pregnancy
People for whom information about how the pregnancy ends is unlikely to be available
People who have already provided a sample under this same study during the current pregnancy
People who are taking part in a blinded aspirin study, or who are taking aspirin at an unknown dose

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sequenom, Inc.

Registry

ClinicalTrials.gov

Start date

2 February 2025

Est. completion

1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Baseline serum samples will be used to evaluate the performance of the Labcorp Preeclampsia Screen assay

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov